Favorable Safety Profile of Tirbanibulin Ointment 1% for Actinic Keratosis: Pooled Results from Two Phase III Studies

Main Article Content

Todd Schlesinger
Neal Bhatia
Brian Berman
Ayman Grada
Albert Torra
David Cutler
Mark Lebwohl


Skin Cancer, Actinic Keratosis, Src Kinase Inhibitor, Tirbanbulin, Safety


Abstract not available.


References not available.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>